Table 3 The most potential HTL epitopes with interacting MHC-II alleles and population coverage.

From: Designing a T-cell epitope-based vaccine using in silico approaches against the Sal k 1 allergen of Salsola kali plant

No

CD4 + T Cell epitopes

Length

Start

End

MHC-II binding alleles

Percentile rank

Smm IC50

Population coverage

World

Europe

Southwest Asia

1

NRPTITFAGTAAEFG

15

101

115

HLA-DQA1*04:01/DQB1*04:02

0.23

159

79.44%

75.61%

76.82%

HLA-DQA1*03:01/DQB1*03:02

1.3

418

HLA-DQA1*05:01/DQB1*02:01

3.2

571

2

KNRPTITFAGTAAEF

15

100

114

HLA-DQA1*04:01/DQB1*04:02

0.26

155

82.76%

77.22%

77.92%

HLA-DQA1*03:01/DQB1*03:02

1.5

464

HLA-DQA1*05:01/DQB1*03:01

7.2

71

3

GTVDFIFGEARSLYL

15

192

206

HLA-DRB1*07:01

0.28

11

85.73

98.31%

84.82%

HLA-DRB1*09:01

2

97

HLA-DRB1*01:01

5.4

30

HLA-DRB1*03:01

5.9

362

HLA-DRB5*01:01

8.5

59

HLA-DPA1*01:03/DPB1*04:01

9

454

4

GANLIVSNSAPRPDG

15

131

145

HLA-DRB3*02:02

0.52

53

55.65%

48.36%

48.11%

HLA-DRB1*13:02

1.4

5.4

HLA-DRB1*03:01

4.7

114.4

HLA-DRB1*09:01

6.4

581

5

AKTFTSLEYIEAAKW

15

318

332

HLA-DPA1*01:03/DPB1*04:01

0.68

98

81.44%

97.02%

23.74%

HLA-DPA1*03:01/DPB1*04:02

1.9

864

HLA-DPB1*02:01

3.4

345

6

LGRAWFEAARVVFSY

15

251

265

HLA-DPA1*02:01/DPB1*14:01

0.76

100

91.74%

92.75%

88.43%

HLA-DQA1*01:02/DQB1*06:02

0.97

79

HLA-DQA1*05:01/DQB1*03:01

3.3

37

HLA-DPB1*05:01

6.1

245

HLA-DRB1*09:01

6.6

208

7

EFGTVDSATLIVESD

15

113

127

HLA-DQA1*04:01/DQB1*04:02

0.78

340

77.41%

7.86%

65.00%

HLA-DQA1*01:02/DQB1*06:02

1.8

111

HLA-DQA1*03:01/DQB1*03:02

2

209

8

GRAWFEAARVVFSYC

15

252

266

HLA-DQA1*01:02/DQB1*06:02

0.98

80

82.00%

81.00%

73.34%

HLA-DPA1*02:01/DPB1*14:01

1.2

98

9

AELESWFQGAVKPVS

15

8

22

HLA-DQA1*01:01/DQB1*05:01

3.4

847

31.46%

32.82%

35.61%

  1. *HTL epitopes with high affinity to binding variant HLA alleles have been shown in bold letters.